New whitepaper discusses how best to utilise next generation techniques for genomic research

New whitepaper discusses how best to utilise next generation techniques for genomic research

 

Oxford, UK – 2 August 2011. Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has released a new white paper discussing the relative merits of DNA microarrays and next generation sequencing (NGS) for human genome analysis. Although the development of genome analysis technologies such as DNA microarrays and NGS has provided the researcher with the unique ability to screen for sequence variants of clinical relevance, each technology has its own unique advantages, meaning that choosing the most appropriate technology for any given study can be challenging. Therefore, the resulting whitepaper, which can be downloaded here, discusses the essential factors to consider when selecting the optimal platform for a specific study.

 

The white paper discusses issues such as the suitability of microarrays and sequencing for various applications, the relative costs associated with each technology and how to overcome the challenges posed by the analysis of large and complex datasets.

 

To download the free whitepaper, visit www.ogt.co.uk/OGTwhitepaper.

 

For further information, please contact:

 

Oxford Gene Technology, Begbroke Science Park, Sandy Lane, Yarnton, Oxford OX5 1PF
T: +44 (0) 1865 856826 ; F: +44 (0) 1865 848684 ; E: products@ogt.co.uk

W: www.ogt.co.uk